• Mashup Score: 2

    Section snippetsFunding Support and Author DisclosuresDr. Fonarow has served as a consultant for Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Eli Lilly, Johnson & Johnson, Medtronic, Merck, Novartis, and Pfizer. Dr Greene has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association (#929502), Amgen, AstraZeneca, Bristol Myers…

    Tweet Tweets with this article
    • 🔥 Revolutioning the concept at the base of clinical inertia, i.e. risk linked to medical treatment. ❤️‍🔥Putting on the spotlight the unperceived risk linked to not starting an effective treatment in a deadly sindrome such as #HeartFailure ⚖️ ☠️ @gcfmd https://t.co/3DmI6Mr7cb https://t.co/5OyKfzOQOG